Indeed, studies reported the possible beneficial effects of [Active Hexose Correlated Compound] supplementation in controlling cancers, especially in a combination with other anticancer therapies like chemotherapy… Immunotherapy targeting these molecules has made substantial impacts in oncology by improving the survival of patients with cancers such as non-small cell lung cancer, bladder cancer, and melanoma… [Active Hexose Correlated Compound] supplementation (3 g/day) enhanced NK cell activity in a small number of patients with various cancers including the prostate.